With the Stock Down Roughly 60% Over the Past 5 Years, Should Investors Buy Nike Before March 31?

Nike reports fiscal Q3 2026 on March 31 with consensus EPS of $0.29 and revenue of $11.22B (flat YoY EPS down materially), and analysts project FY2027 EPS of $2.37 on ~$48.6B revenue. The stock is down ~60% over five years, trades around $53, BTIG lowered its PT from $100 to $90, and Nike faces ~$1.5B of tariff-related costs expected to shave ~120bps off gross margin. Management (Elliott Hill) is pursuing restructuring and operational fixes (Converse slimming, automation, new China leaders); the 3% dividend yield and potential multi-year turnaround give long-term upside but near-term results and guidance are uncertain.

Analysis

Nike’s near-term path is driven less by brand repositioning and more by an operational transition: moving mix, automating distribution, and pruning low-return units. Automation reduces variable labor volatility but raises fixed cost leverage, meaning any revenue slip will amplify EPS downside until throughput and productivity benefits fully ramp (we should expect a 12–36 month realization window).

Competition is now a two-speed market: premium, direct-to-consumer brands can expand margin share while legacy incumbents with large wholesale exposure face slower inventory turns. The second-order supply-chain effect is important — OEMs in Southeast Asia will see lumpy order flows while nearshoring/reshoring vendors (Mexico/India) and automation-capable 3PLs stand to capture reallocated spend, creating sectoral winners outside the obvious apparel names.

Key catalysts are execution milestones (automation yield, wholesale cadence restoration, China order trends) and external policy moves around trade/tariffs; both can flip investor sentiment quickly. Tail risks include a tariff spike or a sustained wholesale destocking that forces material markdowns; conversely, a visible margin inflection from pricing/product mix would validate a multiyear recovery but is unlikely to be instantaneous.

Given elevated event-driven volatility and muted near-term earnings visibility, capital allocation should favor relative-value and asymmetric-option structures rather than outright large directional exposure to Nike equity alone.

Key Decisions for Investors

• Pair trade (3–12 months): Short NKE / Long LULU, equal notional. Rationale: capture continued premium share migration and steadier margin profile at Lululemon versus Nike’s operational retooling. Target relative outperformance of 15–25%; cut if spread tightens/worsens by >10%. Size: 1–2% net portfolio risk.
• Asymmetric recovery wager (18–36 months): Buy long-dated NKE call spread (LEAPS) sized small (0.5–1.0% of portfolio risk) to capture multi-year turnaround upside while limiting downside. Fund by selling shorter-dated calls or puts to reduce cost; objective payoff 3–5x premium if margins and China mix recover. Use position as a convex recovery hedge, not core equity exposure.
• Event/earnings hedge (days–weeks around prints): Buy protective puts or put spreads on NKE expiring 7–30 days after quarterly releases funded by selling near-term calls to collect premium. Replace with calendar spreads if implied vol compresses post-print. Limit allocation to 0.25–0.5% portfolio to manage cost of carry.
• Rotate allocation (6–12 months): Reduce NKE weight and redeploy into NVDA (or NVDA call spreads) and select DTC consumer names like LULU. Rationale: shift from execution-risk consumer exposure into secular growth (AI) and high-quality consumer brands with cleaner inventories. Target sharper upside capture; set stop-losses at 12–15% to protect reallocated capital.